CUMBERLAND PHARMACEUTICALS INC·4

Jan 6, 5:04 PM ET

Jones James 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2025-12-01
Jones James
Director
Transactions
  • Small Acquisition

    Common Stock

    2025-12-01$2.36/sh+18$4244,811 total
  • Small Acquisition

    Common Stock

    2025-12-02$2.24/sh+18$4044,829 total
  • Small Acquisition

    Common Stock

    2025-12-03$2.25/sh+18$4144,847 total
  • Small Acquisition

    Common Stock

    2025-12-04$2.27/sh+18$4144,865 total
  • Small Acquisition

    Common Stock

    2025-12-05$2.34/sh+18$4244,883 total
  • Small Acquisition

    Common Stock

    2025-12-08$2.40/sh+14$3444,897 total
  • Small Acquisition

    Common Stock

    2025-12-09$2.32/sh+14$3244,911 total
  • Small Acquisition

    Common Stock

    2025-12-10$2.60/sh+14$3644,925 total
  • Small Acquisition

    Common Stock

    2025-12-11$2.56/sh+14$3644,939 total
  • Small Acquisition

    Common Stock

    2025-12-12$2.50/sh+14$3544,953 total
  • Small Acquisition

    Common Stock

    2025-12-15$2.82/sh+14$3944,967 total
  • Small Acquisition

    Common Stock

    2025-12-16$3.27/sh+14$4644,981 total
  • Small Acquisition

    Common Stock

    2025-12-17$3.65/sh+10$3744,991 total
  • Small Acquisition

    Common Stock

    2025-12-18$4.19/sh+10$4245,001 total
  • Small Acquisition

    Common Stock

    2025-12-19$4.19/sh+8$3445,009 total
  • Small Acquisition

    Common Stock

    2025-12-22$4.32/sh+7$3045,016 total
  • Small Acquisition

    Common Stock

    2025-12-23$4.13/sh+8$3345,024 total
  • Small Acquisition

    Common Stock

    2025-12-24$4.26/sh+8$3445,032 total
  • Small Acquisition

    Common Stock

    2025-12-26$4.21/sh+8$3445,040 total
  • Small Acquisition

    Common Stock

    2025-12-29$4.01/sh+8$3245,048 total
  • Small Acquisition

    Common Stock

    2025-12-30$3.94/sh+8$3245,056 total
  • Small Acquisition

    Common Stock

    2025-12-31$3.91/sh+7$2745,063 total
Footnotes (1)
  • [F1]The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Documents

1 file
  • 4
    wk-form4_1767737062.xmlPrimary

    FORM 4